BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

BioTrends 

65 Dowlin Forge Road

Exton  Pennsylvania  19341  U.S.A.
Phone: 610-363-3872 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
BioTrends Release: the Majority of Surveyed Gastroenterologists in the EU5 Identify Remicade as Their Most Preferred Biologic for the Treatment of Ulcerative Colitis 5/2/2013 11:01:47 AM    More...
BioTrends Release: ESAs and a New Class of Late Stage Oral HIF-PH Inhibitors May be Impacted by the Fact That Nephrologists Report Initiating ESAs at Lower Hemoglobins 4/4/2013 10:19:46 AM    More...
BioTrends Release: Incorporation of the Anti-JC Virus Antibody Assay and Oral DMAs, Including Aubagio, are Top of Mind Recent Changes in the Management of Multiple Sclerosis Patients for Surveyed U.S. Neurologists 4/2/2013 1:06:14 PM    More...
Two New Strategic Reports Expand Coverage of BioTrends's Biosimilars Advisory Service 4/1/2013 9:53:47 AM    More...
BioTrends Release: Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists 3/26/2013 9:13:59 AM    More...
BioTrends Release: U.S. Physicians Report Diabetic Nephropathy as the Renal Condition With the Highest Unmet Need for Treatment 3/14/2013 10:15:06 AM    More...
BioTrends Announces the Continuation of a Syndicated Report Series: TreatmentTrends: CKD Stages 1-5ND 3/14/2013 9:37:43 AM    More...
Gastroenterologists Indicate They are Increasingly Using Biologics to Treat Patients with Crohn's Disease in Remission than They Were One Year Ago, According to a Recent BioTrends Report 3/6/2013 8:59:05 AM    More...
BioTrends Release: EU5 Nephrologists Report a Decreasing Trend in the Treatment Prevalence of ESAs in the Haemodialysis Patient Population 2/7/2013 10:23:11 AM    More...
BioTrends Release: EU5 Nephrologists Report a Stabilization of Phosphate Binder Treatment Prevalence in the Late-Stage CKD and Dialysis Patient Populations 2/5/2013 10:11:02 AM    More...
12

//-->